Immunotherapy in Bladder Cancer - Arjun Balar

November 7, 2018

(Length of Discussion: 16 min)

Arjun Balar and Alicia Morgans discuss outcomes in bladder cancer trials with a focus on primary endpoints, duration of response, and adverse events. Trials to practice with accurate clinical staging may lead to the ultimate goal of organ conservation in this patient population.


Arjun Balar, MD is the director of the genitourinary medical oncology program at NYU Langone’s Perlmutter Cancer Center.

Alicia Morgans, MD, MPH